Drawing for PROFIBRIX

USPTO serial 79075468

PROFIBRIX

Reviewed by CopyMark Law Group

Reg. 4069082Status 404
Filing date
Status date
Registration date
Dec 13, 2011
Examiner
HACK, ANDREA R
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PROFIBRIX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment of bleeding and for tissue sealing; pharmaceutical preparations and substances for use as tissue sealants; haemostatic pharmaceutical compositions; pharmaceutical powder compositions for use as tissue sealants and/or as haemostatic compositions; pharmaceutical compositions for topical application to wounds; pharmaceutical compositions for topical application during surgical procedures for the treatment of bleeding and for tissue sealing; wound dressings; surgical dressings; bandages for dressing wounds; medicated wound dressings impregnated with tissue sealants and/or haemostatic compositions; medicated bandages impregnated with tissue sealants and/or haemostatic compositions; wound dressings, surgical dressings and bandages for dressing wounds, all incorporating tissue sealants and/or haemostatic compositions; pharmaceutical preparations and substances for use in delivery of drugs, genes, other therapeutic products or diagnostic agents, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations for the treatment of internal bleeding; blood platelet substitutes; pharmaceutical compositions for coating blood vessels for the prevention and treatment of cardiovascular diseases and disorders; pharmaceutical compositions for intravascular administration for the prevention and treatment of cardiovascular diseases and disorders; pharmaceutical dry powder compositions comprising fibrin polymer for coating the internal surface of blood vessels for the prevention and treatment of cardiovascular diseases and disordersSECTION 71 - CANCELLED
010Surgical, medical, dental and veterinary apparatus and instruments for administration of pharmaceutical compositions, namely, drug delivery systems; drug delivery systems, sold empty, for the delivery of pharmaceutical compositions for the treatment of bleeding and/or tissue sealing; drug delivery systems, sold empty, for the topical delivery of powdered pharmaceutical tissue sealants and/or haemostatic compositions; drug delivery systems, sold empty, for the delivery of tissue sealants to an internal or external surface of a patient; drug delivery systems, sold empty, for the delivery of haemostatic compositions by spraying; drug delivery systems, sold empty, for the delivery of pharmaceutical tissue sealants and/or haemostatic compositions during surgical procedures; surgical, medical, dental and veterinary apparatus and instruments for the prevention and treatment of cardiovascular diseases and disorders; drug delivery systems, sold empty, for intravascular delivery of pharmaceutical compositions for the prevention and/or treatment of cardiovascular diseases and disordersSECTION 71 - CANCELLED
042Pharmaceutical drug development services; design services of new drug delivery systems; development of pharmaceutical formulations; scientific research and industrial research services in the field of pharmaceuticals and drug delivery systemsSECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 17, 2020DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Apr 17, 2020DETHDEATH OF INTERNATIONAL REGISTRATION
May 17, 2019INNTTOTAL INVALIDATION PROCESSED BY THE IB
Mar 28, 2019INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Mar 28, 2019INPCINVALIDATION PROCESSED
Mar 20, 2019INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jul 20, 2018C71TCANCELLED SECTION 71
Aug 29, 2012FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Aug 7, 2012FICSFINAL DISPOSITION NOTICE SENT TO IB
Aug 7, 2012FIMPFINAL DISPOSITION PROCESSED
Mar 13, 2012FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 13, 2011R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 27, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 7, 2011NPUBNOTICE OF PUBLICATION
Aug 22, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 18, 2011CNEAEXAMINERS AMENDMENT MAILED
Aug 18, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Aug 18, 2011XAECEXAMINER'S AMENDMENT ENTERED
Aug 18, 2011CNEAEXAMINERS AMENDMENT -WRITTEN
Aug 10, 2011TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Aug 10, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 10, 2011ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED
May 25, 2011OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 4, 2011OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 4, 2011OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 2, 2011DOCKASSIGNED TO EXAMINER
Feb 11, 2011CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 10, 2011CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 20, 2011RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jul 20, 2010CNSLLETTER OF SUSPENSION MAILED
Jul 20, 2010CNSLSUSPENSION LETTER WRITTEN
Jul 15, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jul 15, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 14, 2010ALIEASSIGNED TO LIE
Jun 29, 2010TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 22, 2010RFNTREFUSAL PROCESSED BY IB
Dec 29, 2009RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 29, 2009RFRRREFUSAL PROCESSED BY MPU
Dec 24, 2009RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 23, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 16, 2009DOCKASSIGNED TO EXAMINER
Dec 11, 2009MAFRAPPLICATION FILING RECEIPT MAILED
Dec 7, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 4, 2009REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance